Improving The Delivery Efficiency Of Nanomedicines To Tumour Tissue
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
This research program seeks to develop improved nanomedicines for treating cancer. This will be achieved by targeting the poor delivery efficiency that currently hinders the translation of existing nanomedicines from laboratory to clinic. Successful completion will result in new nanomedicines that effectively target the tumour tissue and display superior therapeutic efficacy, and that will ultimately be developed into new treatments that improve patient outcomes.
Biocompatible Gadolinium-free Contrast Agents For Molecular Targeted MR Imaging
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
Building on the biomedical engineering of USPIOs, this project expects to generate new probing tools for non-invasive molecular imaging and affect subsequent clinical imaging through earlier and more accurate diagnosis of diseases. The project will allow the delivery of new knowledge in the emerging field of nanomedicine with high clinical translation potentials.
Repairing Soft Tissues With Engineered Elastic Biomaterials
Funder
National Health and Medical Research Council
Funding Amount
$2,914,215.00
Summary
There is an urgent medical demand for implantable soft materials that harmonise with surrounding elastic tissue and promote repair. This integrated research program leverages our leading knowledge of human elastic protein. The program’s goals are to develop powerful platform technologies that use this elastic protein, and deliver a new generation of elastic surgical products that can help treat pelvic organ prolapse and repair damaged heart tissue.
Novel Nanotechnology Strategies For Drug Co-delivery And Combined Therapies In The Brain
Funder
National Health and Medical Research Council
Funding Amount
$1,512,250.00
Summary
Key challenges for treating brain diseases include effective delivery of drugs into the brain and targeted delivery to pathogenic areas. I have developed two world-first drug delivery systems that address these challenges. This project will expand their loading and brain delivery capability to deliver a broad range of novel multiple therapeutics to target sites in the brain. Human brain disease models will be used for systematic preclinical evaluation of novel delivery systems and therapeutics.
A Long-Lasting Oral Drug Delivery System Using Spiky Silica Nanoparticles
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
This project aims to develop a novel silica nanoparticle-based delivery system for long-lasting oral drug delivery. The particles will be engineered with a spiky morphology that will increase adhesion to the gastrointestinal tract enabling sustained drug release for days or even weeks. Longer lasting oral drug formulations would make it much easier for patients to adhere to the treatment schedules required in chronic diseases like HIV and increase the effectiveness of therapy.